Piper Sandler lowered the firm’s price target on Amphastar (AMPH) to $25 from $30 and keeps a Neutral rating on the shares following quarterly results. The firm cites tempered generics sales estimates and lower gross margins. Competitive headwinds remain a challenge, Piper adds.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMPH: